Pediatrix Medical Group (FRA:PDC) Current Accrued Expense: €211 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PDC Pediatrix Medical Group Inc FRA:PDC
55 GF Score
Price €22.60
GF Value €11.71
! 7 Warning Signs
View Full Analysis

What is Pediatrix Medical Group Current Accrued Expense?

Pediatrix Medical Group FRA:PDC +1.80% 55 Current Accrued Expense is €211 Mil as of Jun. 2026. GuruFocus rates FRA:PDC with a GF Score™ of 55/100 and a GF Value™ of €11.71. The stock has 7 warning signs investors should review.

Pediatrix Medical Group's Current Accrued Expense for the quarter that ended in Jun. 2026 was €211 Mil.

Pediatrix Medical Group's quarterly Current Accrued Expense declined from Dec. 2025 (€293 Mil) to Mar. 2026 (€156 Mil) but then increased from Mar. 2026 (€156 Mil) to Jun. 2026 (€211 Mil).

Pediatrix Medical Group's annual Current Accrued Expense increased from Dec. 2023 (€256 Mil) to Dec. 2024 (€303 Mil) but then declined from Dec. 2024 (€303 Mil) to Dec. 2025 (€293 Mil).

Pediatrix Medical Group Current Accrued Expense Related Terms

Pediatrix Medical Group Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Pediatrix Medical Group's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pediatrix Medical Group Current Accrued Expense Chart

Pediatrix Medical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 285.39 290.17 256.45 302.55 292.66

Pediatrix Medical Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 199.34 232.00 292.66 156.48 210.96
FRA:PDC
55GF Score
Pediatrix Medical Group Inc FRA:PDC
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pediatrix Medical Group Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of €211 Mil mean?
Pediatrix Medical Group (FRA:PDC) has a Current Accrued Expense of €211 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Pediatrix Medical Group and its competitors.
Is Pediatrix Medical Group's Current Accrued Expense too high?
Pediatrix Medical Group's current Current Accrued Expense is €211 Mil. Overall, Pediatrix Medical Group has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Current Accrued Expense compare to ADUS and AVAH?
Pediatrix Medical Group's Current Accrued Expense of €211 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Healthcare Providers & Services company?
A good Current Accrued Expense depends on the Healthcare Providers & Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Pediatrix Medical Group and its competitors. Pediatrix Medical Group's current Current Accrued Expense is €211 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (FRA:PDC) has a current Current Accrued Expense of €211 Mil. The stock's GF Value™ is €11.71, compared to a current price of €22.60 — trading 93% above its estimated fair value. The current Current Accrued Expense is €211 Mil. Pediatrix Medical Group's overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Current Accrued Expense is €211 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of €22.60 is trading 93% above its estimated GF Value™ of €11.71.

Key valuation signals for FRA:PDC:

  • Current Accrued Expense: €211 Mil
  • GF Value™: €11.71 vs. price of €22.60 (93% above fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pediatrix Medical Group Business Description

Other Exchanges MD:USA
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
55GF Score

Get the complete analysis for FRA:PDC

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.60
Price
€11.71
GF Value